Physician profile
Barath Krishnan
NPI 1922362151
$14,604.76
in general payments reported to CMS, 2019-2025
19 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $5,047 · 2021: $4,032 · 2022: $2,031 · 2023: $2,079 · 2024: $524 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,489 · Food and Beverage: $1,472 · Travel and Lodging: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,489.00 |
| Food and Beverage | $1,472.15 |
| Travel and Lodging | $301.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,836.12 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $115.95 | 2019-2024 | Tisseel |
| Integra Lifesciences Corporation | $100.79 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mozarc Medical US LLC | $99.50 | 2023-2025 | Argyle |
| Endo Pharmaceuticals INC. | $65.99 | 2019 | |
| Smith+Nephew, INC. | $49.77 | 2023 | Collagenase Santyl, Regranex |
| Tela Bio, INC. | $48.08 | 2020-2022 | |
| Abbvie INC. | $47.79 | 2023-2024 | |
| Melinta Therapeutics, LLC | $33.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.92 | 2022 | |
| Heron Therapeutics, INC. | $27.35 | 2023 | Zynrelef |
| Reprise Biomedical, INC. | $24.67 | 2023 | Miro3d |
| Innocoll Pharmaceuticals Limited | $22.09 | 2022 | |
| Kci USA, INC. | $18.78 | 2019 | |
| Shire North American Group INC | $18.33 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.99 | 2022 | |
| Mallinckrodt Enterprises LLC | $17.80 | 2019 | |
| Avanos Medical | $16.22 | 2019 | |
| Stryker Corporation | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barath Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.